Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials
Article in BMC Gastroenterology (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in BMC Gastroenterology (March 2024)
Article in Gastroenterology & hepatology (March 2024)
Article in Revista mexicana de enfermedades inflamatorias inmunomediadas (June 2023)